banner ad
banner ad

Looking So Good Doesn’t Have To Hurt So Bad

February 20, 2008 |

Mesotherapy has been hailed as a breakthrough in cosmetic procedures using lipodissolve to eliminate unwanted fat and cellulite. But even though this type of treatment is non-surgical, there is still a price: several – sometimes hundreds – of painful needle injections into the affected areas of the skin.

(PRWEB) February 20, 2008 — AA Advanced Technology Inc. has produced an insightful video comparing injection vs. MesoDerm treatments showing the effects during and after the procedure.

MesoDerm has proven wrong the old adage, “No pain, no gain,” by using Mesoporation as the means to deliver active ingredients into the target area through hundreds of thousands of tiny channels in the skin. A smooth roller ball gently delivers lipodissolve drugs in a treatment that is comfortable and relaxing. The alternative is a stressful series of injections that can leave bruising and discomfort. Below are examples of how Lipodissolve treatments using the MesoDerm delivery system can help patient’s look and feel better:

Body Profiling – This procedure can be used for shaping the waistline, buttocks, arms, ankles, knees, thighs and other body areas. The process rejuvenates the skin, breaks down fat cells and tones tissue.

Fat Treatment / Second Chin / Cellulites – Mesotherapy components are introduced painlessly through mesopores into fat tissue causing the break down and shrinkage of fat cells. Fat is then metabolized by the liver and expelled from the body.

*Mesoporation is a process developed by Microlab Biomedical, an Italian Bioengineering Company, and American doctor Aleksy Dobradin M.D. MesoDerm® is FDA approved and registered as a Class III medical device. It is available in the USA and can only be purchased by licensed physicians.

We are looking for distributors and group seminar partners in all states.

For more information please contact:
Kamil Kulczycki, Operations Manager
Phone: 1.888.MESO.661
Fax: 1.773.481.2516

About the Author (Author Profile)

Comments are closed.

banner ad
banner ad